multimmune GmbH
.......... delivering innovative, clinical-stage broad-spectrum cancer theranostics

NEWS & PUBLICATIONS

News and Updates are now collated on our Linkedin page.

multimmune's platform technologies have been fully evaluated in the pre-clinical and clinical settings and data widely published in the international, peer-reviewed literature.

A full list of publications relating to membrane Hsp70 and its use for the development of new diagnostic and therapeutic approaches can be accessed HERE.

Further information provided on request.


Mail